Atlas Private Wealth Advisors Karyopharm Therapeutics Inc. Transaction History

Atlas Private Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Apr 21, 2022	SELL	$5.21 - $8.61 $18,235 - $30,134	-3,500 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$4.45 - $10.63 $8,900 - $21,260	-2,000 Reduced 36.36%	3,500 $20,000
Q2 2021 Aug 02, 2021	SELL	$8.11 - $11.11 $67,150 - $91,990	-8,280 Reduced 60.09%	5,500 $57,000
Q1 2021 Apr 28, 2021	SELL	$9.85 - $17.69 $303,971 - $545,913	-30,860 Reduced 69.13%	13,780 $145,000
Q4 2020 Jan 29, 2021	SELL	$14.15 - $17.19 $42,450 - $51,570	-3,000 Reduced 6.3%	44,640 $691,000
Q3 2020 Oct 27, 2020	SELL	$14.14 - $19.71 $14,140 - $19,710	-1,000 Reduced 2.06%	47,640 $696,000
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $807,424 - $1.23 Million	48,640 New	48,640 $921,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $70.2M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Atlas Private Wealth Advisors with notifications on news.